Literature DB >> 9630662

Real-time measurement of ischemia-evoked glutamate release in the cerebral cortex of four and eleven vessel rat occlusion models.

L P Caragine1, H K Park, F G Diaz, J W Phillis.   

Abstract

Interstitial levels of the neurotransmitter glutamate and cerebral blood flow changes were compared in two models of rat forebrain ischemia using the dialysis electrode technique and laser doppler flowmetry with brain temperature controlled. Ten-minute periods of cerebral ischemia were elicited by the four and an eleven vessel occlusion and compared to carotid artery transection. Elapsed time from the onset of ischemia to the ischemic plateau was 76.8+/-57.9 s in 4VO vs. 14.8+/-1.3 s in 11VO animals. Percent residual cerebral blood flow (CBF) was 13.5+/-8.8% during 4VO as opposed to 4.5+/-2.9% during 11VO. Concomitantly, cerebral glutamate levels rose to 255. 7+/-72.8 micromol l-1 in the 4VO animals in comparison with levels of 138.5+/-78.7 and 135.7+/-40.2 micromol l-1 in the 11VO and carotid transection animals. During the first 89.6+/-47.4 s of reperfusion, glutamate levels rose to a second higher peak of 315. 1+/-179.2 micromol l-1 in 7 of 12 animals. Following reperfusion, glutamate levels in the 4VO and 11VO animals returned towards basal levels. This study demonstrates that 11VO causes a rapid drop in CBF to near zero levels, better mimicking complete forebrain ischemia than the traditional 4VO technique. Moreover, the 'low flow' state of cerebral ischemia, produced by traditional 4VO, results in a higher interstitial level of glutamate than a 'no flow' state, as exhibited by the 11VO technique. The dialysis electrode, used simultaneously with laser doppler flowmetry, real-time data acquisition, and continuous brain temperature control, in this new rat model, provides real-time evidence that glutamate levels in the interstitial space are enhanced during a low flow state of cerebral ischemia. Furthermore, not before demonstrated, glutamate transients are seen to occur during the first 90 s of reperfusion, and, to the best of our knowledge, the glutamate levels recorded by this technique are the highest in the literature. Copyright 1998 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9630662     DOI: 10.1016/s0006-8993(98)00182-6

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  8 in total

Review 1.  Medicinal chemistry of competitive kainate receptor antagonists.

Authors:  Ann M Larsen; Lennart Bunch
Journal:  ACS Chem Neurosci       Date:  2010-12-10       Impact factor: 4.418

2.  Neuroprotective effects by nimodipine treatment in the experimental global ischemic rat model : real time estimation of glutamate.

Authors:  Seok Keun Choi; Gi-Ja Lee; Samjin Choi; Youn Jung Kim; Hun-Kuk Park; Bong Jin Park
Journal:  J Korean Neurosurg Soc       Date:  2011-01-31

3.  Effect of ageing and ischemia on enzymatic activities linked to Krebs' cycle, electron transfer chain, glutamate and aminoacids metabolism of free and intrasynaptic mitochondria of cerebral cortex.

Authors:  Roberto Federico Villa; Antonella Gorini; Siegfried Hoyer
Journal:  Neurochem Res       Date:  2009-12       Impact factor: 3.996

Review 4.  Pharmacology of AMPA/kainate receptor ligands and their therapeutic potential in neurological and psychiatric disorders.

Authors:  G J Lees
Journal:  Drugs       Date:  2000-01       Impact factor: 9.546

5.  Astrocytic clasmatodendrosis in hippocampal organ culture.

Authors:  R E Hulse; J Winterfield; P E Kunkler; R P Kraig
Journal:  Glia       Date:  2001-02       Impact factor: 7.452

6.  Seizure activity in the rat hippocampus, perirhinal and prefrontal cortex associated with transient global cerebral ischemia.

Authors:  D A Caruana; C Nesbitt; D G Mumby; C A Chapman
Journal:  J Neural Transm (Vienna)       Date:  2008-02-04       Impact factor: 3.575

7.  The role of glutamate release on voltage-dependent anion channels (VDAC)-mediated apoptosis in an eleven vessel occlusion model in rats.

Authors:  Eunkuk Park; Gi-Ja Lee; Samjin Choi; Seok-Keun Choi; Su-Jin Chae; Sung-Wook Kang; Youngmi Kim Pak; Hun-Kuk Park
Journal:  PLoS One       Date:  2010-12-21       Impact factor: 3.240

Review 8.  The Mechanisms of Traditional Chinese Medicine Underlying the Prevention and Treatment of Parkinson's Disease.

Authors:  Xiaoliang Li; YaNan Zhang; Yu Wang; Jing Xu; Ping Xin; YongHai Meng; Qiuhong Wang; Haixue Kuang
Journal:  Front Pharmacol       Date:  2017-09-19       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.